10 completed. 10 Phase 1, 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 10 | Completed 10 |
| Phase 2 | 5 | Completed 5 |
Follow Food Allergy: new trials by email Literature Review of Food Allergy trials Research Report on Food Allergy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PK/PD Study of IN-001 Sublingual Spray in Healthy Adults Epinephrine Auto-Injector 0.3 mg/0.3 mL, Epinephrine 0.3 mg intramuscular manual injection via a syringe and needle, IN-001 9.06 mg Sublingual Spray - Food Allergy, Anaphylaxis | Phase 1 | Completed | Insignis Therapeutics, Inc. | 32 | 2025-10-24 | 2026-05-05 |
| JAK Inhibition in Food Allergy Abrocitinib - Food Allergy | Phase 1 | Completed | Icahn School of Medicine at Mount Sinai | 71 | 2022-05-16 | 2025-07-04 |
| ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults Low dose ADP101, High dose ADP101, Pooled Placebo - Food Allergy | Phase 1 / Phase 2 | Completed | Alladapt Immunotherapeutics, Inc. | 73 | 2021-04-20 | 2024-05-16 |
| A Study to Assess Primarily the Tolerability and Safety of SAR439794 After Repeated Sublingual Daily Administration in Peanut Allergic Adult and Adolescent Patients Glucopyranosyl Lipid A (GLA), Sublingual Immuno Therapy (SLIT) Peanut Extract (PE), Placebo for GLA - Food Allergy | Phase 1 | Completed | Sanofi | 27 | 2018-05-07 | 2022-04-25 |
| Study Using Xolair in Rush Multi Oral Immunotherapy in Multi Food Allergic Patients Xolair, Placebo - Food Allergy | Phase 1 / Phase 2 | Completed | Stanford University | 48 | 2015-03-18 | 2018-01-12 |
| Efficacy and Safety of Viaskin Milk in Children With IgE-Mediated Cow's Milk Allergy Viaskin Milk 150 mcg, Viaskin Milk 300 mcg, Viaskin Milk 500 mcg - Food Allergy | Phase 1 / Phase 2 | Completed | DBV Technologies | 198 | 2014-11-01 | 2024-11-20 |
| Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial Omalizumab, placebo - Peanut Allergy, Food Allergy | Phase 1 / Phase 2 | Completed | Boston Children's Hospital | 36 | 2013-01-01 | 2023-02-21 |
| Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance Liquid peanut extract (Peanut SLIT) - Peanut Hypersensitivity, Food Hypersensitivity | Phase 1 / Phase 2 | Completed | University of North Carolina, Chapel Hill | 54 | 2011-06-01 | 2019-06-12 |
| Atopy Patch Test in Children With Food Allergy-related Gastrointestinal Symptoms Atopy patch test with food allergen - Food Allergy | Phase 1 | Completed | Mahidol University | 40 | 2010-04-01 | 2015-09-18 |
| Trichuris Suis Ova in Peanut and Tree Nut Allergy Trichuris suis ova (TSO) - Food Allergy | Phase 1 | Completed | Beth Israel Deaconess Medical Center | 18 | 2010-02-01 | 2017-02-03 |
Food Hypersensitivity (10) · Peanut Hypersensitivity (5) · Hypersensitivity (2) · Milk Hypersensitivity (2) · Nut Hypersensitivity (2) · Anaphylaxis (1) · Egg Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Shellfish Hypersensitivity (1) · Wheat Hypersensitivity (1)
Hypersensitivity, Immediate (9) · Immune System Diseases (9) · Hypersensitivity (8) · Nut and Peanut Hypersensitivity (5)
Omalizumab (2) · Epinephrine (1) · Needles (1) · abrocitinib (1) · gamma-carboxyglutamyl-gamma-carboxyglutamic acid (1) · glucopyranosyl lipid-A (1)
Alladapt Immunotherapeutics, Inc. (1) · Beth Israel Deaconess Medical Center (1) · Boston Children's Hospital (1) · DBV Technologies (1) · Icahn School of Medicine at Mount Sinai (1) · Insignis Therapeutics, Inc. (1) · Mahidol University (1) · Sanofi (1) · Stanford University (1) · University of North Carolina, Chapel Hill (1)
United States (9) · Canada (1) · Thailand (1)
Andrew MacGinnitie, MD, PhD (1) · Emma Guttman, MD, PhD (1) · Jacqueline Pongracic, MD (1) · Jonathan Spergel, MD, PhD (1) · Kari Nadeau, MD PhD (1) · Kari Nadeau, MD, PhD (1) · Lynda C Schneider, MD (1) · Marie-Helene Jouvin, MD (1) · Mei-Lun Wang, MD (1) · Nancy Sweitzer (1) · Nualanong Visitsunthorn, MD (1) · Scott Sicherer, MD (1) · Wesley Burks, MD (1)
PMID 27979025, PMID 29242014, PMID 33782956, PMID 34755130, PMID 38407859, PMID 38814736
R01AT004435 (1), U19AI104209 (1)